2575731-47-2

ETAP is a MAO-A and MAO-B inhibitor. ETAP has antidepressant-like effect. ETAP can be used for research of major depressive disorder[1].

[1] Presa MH, et al. Antidepressant-like Effect of 1-(2-(4-(4-Ethylphenyl)-1H-1,2,3-triazol-1-yl)phenyl)ethan-1-one in Mice: Evidence of the Contribution of the Serotonergic System. ACS Chem Neurosci. 2023 Jun 21;14(12):2333-2346. DOI:10.1021/acschemneuro.3c00108